Skip to main content
SpringerLink
Log in

Relation of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and left atrial volume index to left ventricular function in chronic hemodialysis patients

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Cardiovascular disease is the major cause of death in hemodialysis (HD) patients. We investigated the relation of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and left atrial volume index (LAVi) to left ventricular function in chronic HD patients. A total of 117 patients were enrolled as subjects (74 men and 43 women). Echocardiography was performed to evaluate the left atrial volume index (LAVi) and left ventricular mass index (LVMI). Diastolic left ventricular function was estimated as E/E′ by tissue Doppler imaging with cardiac ultrasonography. Serum NT-proBNP was measured at the time of echocardiographic measurements. Multiple regression analysis showed that LAVi (F = 24.372, p < 0.0001) and E/E′ (F = 23.473, p < 0.0116) were significant predictors for serum NT-proBNP levels, and LVMI (F = 46.807, p < 0.0001) was a best predictor for LAVi among associated factors. These findings suggest that serum NT-proBNP and LAVi are both good biomarkers for predicting the LV remodeling in chronic HD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Villar E, Remontet L, Labeeuw M, Ecochard R (2007) Effect of age, gender, and diabetes on excess death in end-stage renal failure. J Am Soc Nephrol 18:2125–2134

    Article  PubMed  Google Scholar 

  2. Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, Collins AJ (2005) Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998–1999. J Am Soc Nephrol 16:489–495

    Article  PubMed  Google Scholar 

  3. Collins AJ (2003) Cardiovascular mortality in end-stage renal disease. Am J Med Sci 325:163–167

    Article  PubMed  Google Scholar 

  4. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1995) The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5:2024–2031

    PubMed  CAS  Google Scholar 

  5. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, Sutton MSJ, Stewart W (2006) Recommendations for chamber quantification. Eur J Echocardiogr 7:79–108

    Google Scholar 

  6. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB (2002) Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 90:1284–1289

    Article  PubMed  Google Scholar 

  7. Tsang TS, Barnes ME, Gersh BJ, Takemoto Y, Rosales AG, Bailey KR, Seward JB (2003) Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography. J Am Coll Cardiol 42:1199–1205

    Article  PubMed  Google Scholar 

  8. Kizer JR, Bella JN, Palmieri V, Liu JE, Best LG, Lee ET, Roman MJ, Devereux RB (2006) Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). Am Heart J 151:412–418

    Article  PubMed  Google Scholar 

  9. Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto I, Nishino K, Yoshimasa T, Nakao K (1995) Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptides as an “emergency” cardiac hormone against ventricular overload. J Clin Invest 96:1280–1287

    Article  PubMed  CAS  Google Scholar 

  10. Karavidas A, Lazaros G, Matsakas E, Farmakis D, Parissis J, Paraskevaidis IA, Michailidis C, Avramidis D, Zacharoulis A, Arapi S, Kaoukis A, Zacharoulis A (2008) Clinical value of B-type natriuretic peptide for the assessment of left ventricular filling pressure in patients with systolic heart failure and inconclusive tissue Doppler indexes. Heart Vessels 23:181–186

    Article  PubMed  Google Scholar 

  11. Ito S, Murai S, Sugiura M, Yoshida T, Fukutomi T (2007) Predictors of congestive heart failure in patients on maintenance hemodialysis. Circ J 71:1424–1429

    Article  PubMed  Google Scholar 

  12. Rosner MH (2007) Measuring risk in end-stage renal disease: is N-terminal pro brain natriuretic peptide a useful marker? Kidney Int 71:481–483

    Article  PubMed  CAS  Google Scholar 

  13. Roberts MA, Hare DL, Ratnaike S, Ierino FL (2006) Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease. Am J Kidney Dis 48:341–360

    Article  PubMed  CAS  Google Scholar 

  14. Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbely A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28:2539–2550

    Article  PubMed  Google Scholar 

  15. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553

    Article  PubMed  CAS  Google Scholar 

  16. Schiller NB (1991) Two-dimensional echocardiographic determination of left ventricular volume, systolic function, and mass. Summary and discussion of the 1989 recommendations of the American Society of Echocardiography. Circulation 84:1280–1287

    Google Scholar 

  17. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358–367

    PubMed  CAS  Google Scholar 

  18. Lester SJ, Ryan EW, Schiller NB, Foster E (1999) Best method in clinical practice and in research studies to determine left atrial size. Am J Cardiol 84:829–832

    Article  PubMed  CAS  Google Scholar 

  19. Moller JE, Hillis GS, Oh JK, Seward JB, Reeder GS, Wright RS, Park SW, Bailey KR, Pellikka PA (2003) Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation 107:2207–2212

    Article  PubMed  Google Scholar 

  20. Tripepi G, Benedetto FA, Mallamaci F, Tripepi R, Malatino L, Zoccali C (2006) Left atrial volume in end-stage renal disease: a prospective cohort study. J Hypertens 24:1173–1180

    Article  PubMed  CAS  Google Scholar 

  21. Fujiu A, Ogawa T, Matsuda N, Ando Y, Nitta K (2008) Aortic arch calcification and arterial stiffness are independent factors for diastolic left ventricular dysfunction in chronic hemodialysis patients. Circ J 72:1768–1772

    Article  PubMed  CAS  Google Scholar 

  22. Nishimura RA, Tajik AJ (1997) Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician’s Rosetta Stone. J Am Coll Cardiol 30:8–18

    Article  PubMed  CAS  Google Scholar 

  23. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ (2000) Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102:1788–1794

    PubMed  CAS  Google Scholar 

  24. Gunes Y, Guntekin U, Tuncer M, Sahin M (2009) Improved left and right ventricular functions with trimetazine in patients with heart failure: a tissue Doppler study. Heart Vessels 24:277–282

    Article  PubMed  Google Scholar 

  25. Duzenli MA, Ozdemir K, Aygul N, Soylu A, Aygul MU, Gok H (2009) Comparison of myocardial performance index obtained either by conventional echocardiography or tissue Doppler echocardiography in healthy subjects and patients with heart failure. Heart Vessels 24:8–15

    Article  PubMed  Google Scholar 

  26. Sohn DW, Chai IH, Lee DJ, Kim HS, Oh BH, Lee MM, Park YB, Choi YS, Seo JD, Lee YW (1997) Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 30:474–480

    Article  PubMed  CAS  Google Scholar 

  27. Dokainish H, Zoghbi WA, Lakkis NM, Ambriz E, Patel R, Quinones MA, Nagueh SF (2004) Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters. Circulation 109:2432–2439

    Article  PubMed  Google Scholar 

  28. Minoshima M, Noda A, Nishizawa T, Hara Y, Sugiura M, Iino S, Nagata K, Koike Y, Murohara T (2009) Endomyocardial radial strain imaging and left ventricular relaxation abnormalities in patients with hypertrophic cardiomyopathy or hypertensive left ventricular hypertrophy. Circ J 73:2294–2299

    Article  PubMed  Google Scholar 

  29. Gulel O, Soylu K, Yuksel S, Karaoglanoglu M, Cengiz K, Dilek M, Hamiseyev C, Kale A, Arik N (2008) Evidence of left ventricular systolic and diastolic dysfunction by color tissue Doppler imaging despite normal ejection fraction in patients on chronic hemodialysis patients. Echocardiography 25:569–574

    Article  PubMed  Google Scholar 

  30. Wang AY, Wang M, Lam CW, Chan IH, Zhang Y, Sanderson JE (2008) Left ventricular filling pressure by Doppler echocardiography in patients with end-stage renal disease. Hypertension 52:107–114

    Article  PubMed  CAS  Google Scholar 

  31. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME (2001) Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 12:2759–2767

    PubMed  CAS  Google Scholar 

  32. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS (2004) Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol 15:1029–1037

    Article  PubMed  Google Scholar 

  33. Suresh M, Farrington K (2005) Natriuretic peptides and the dialysis patient. Semin Dial 18:409–419

    Article  PubMed  Google Scholar 

  34. Wang AY, Lam CW, Yu CM, Wang M, Chan IH, Zhang Y, Lui SF, Sanderson JE (2007) N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients. J Am Soc Nephrol 18:321–330

    Article  PubMed  CAS  Google Scholar 

  35. David S, Kumpers P, Seidler V, Biertz F, Haller H, Fliser D (2008) Diagnostic value of N-terminal pro-B-type natriuretic peptide (NNT-ProBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis. Nephrol Dial Transplant 23:1370–1377

    Article  PubMed  CAS  Google Scholar 

  36. Tripepi G, Benedetto FA, Mallamaci F, Tripepi R, Malatino L, Zoccali C (2007) Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study. J Am Soc Nephrol 18:1316–1322

    Article  PubMed  Google Scholar 

  37. Tripepi G, Mattace-Raso F, Mallamaci F, Benedetto FA, Witteman J, Malatino L, Zoccali C (2009) Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease. Hypertension 54:818–824

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank the medical staff of dialysis units in the Hidaka Hospital for collecting medical records. This work was supported by grants from the Japan Research Promotion Society for Cardiovascular Diseases the International Research.

Author information

Authors and Affiliations

  1. Department of Medicine, Kidney Center, Tokyo Women’s Medical University, Tokyo, Japan

    Mayuko Yamazaki, Tetsuya Ogawa, Noriko Tamei & Kosaku Nitta

  2. Hidaka Hospital, Gunma, Japan

    Yoshitaka Ando

  3. Internal Medicine, Kidney Center, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan

    Tetsuya Ogawa

Authors
  1. Mayuko Yamazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tetsuya Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Noriko Tamei
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshitaka Ando
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kosaku Nitta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tetsuya Ogawa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamazaki, M., Ogawa, T., Tamei, N. et al. Relation of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and left atrial volume index to left ventricular function in chronic hemodialysis patients. Heart Vessels 26, 421–427 (2011). https://doi.org/10.1007/s00380-010-0066-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-010-0066-4

Keywords

Search

Navigation